232 related articles for article (PubMed ID: 19845910)
1. IL-21: roles in immunopathology and cancer therapy.
Søndergaard H; Skak K
Tissue Antigens; 2009 Dec; 74(6):467-79. PubMed ID: 19845910
[TBL] [Abstract][Full Text] [Related]
2. A positive feedback loop of IL-21 signaling provoked by homeostatic CD4+CD25- T cell expansion is essential for the development of arthritis in autoimmune K/BxN mice.
Jang E; Cho SH; Park H; Paik DJ; Kim JM; Youn J
J Immunol; 2009 Apr; 182(8):4649-56. PubMed ID: 19342640
[TBL] [Abstract][Full Text] [Related]
3. Endogenous IL-21 restricts CD8+ T cell expansion and is not required for tumor immunity.
Søndergaard H; Coquet JM; Uldrich AP; McLaughlin N; Godfrey DI; Sivakumar PV; Skak K; Smyth MJ
J Immunol; 2009 Dec; 183(11):7326-36. PubMed ID: 19915059
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-21 signaling: functions in cancer and autoimmunity.
Davis ID; Skak K; Smyth MJ; Kristjansen PE; Miller DM; Sivakumar PV
Clin Cancer Res; 2007 Dec; 13(23):6926-32. PubMed ID: 18056166
[TBL] [Abstract][Full Text] [Related]
5. IL-21: a novel IL-2-family lymphokine that modulates B, T, and natural killer cell responses.
Habib T; Nelson A; Kaushansky K
J Allergy Clin Immunol; 2003 Dec; 112(6):1033-45. PubMed ID: 14657853
[TBL] [Abstract][Full Text] [Related]
6. Immune modulation with interleukin-21.
Bhave NS; Carson WE
Ann N Y Acad Sci; 2009 Dec; 1182():39-46. PubMed ID: 20074273
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-21: a new modulator of immunity, infection, and cancer.
Brandt K; Singh PB; Bulfone-Paus S; Rückert R
Cytokine Growth Factor Rev; 2007; 18(3-4):223-32. PubMed ID: 17509926
[TBL] [Abstract][Full Text] [Related]
8. Analysis of Th1 and Th2 cytokines expressing CD4+ and CD8+ T cells in rheumatoid arthritis by flow cytometry.
Berner B; Akça D; Jung T; Muller GA; Reuss-Borst MA
J Rheumatol; 2000 May; 27(5):1128-35. PubMed ID: 10813277
[TBL] [Abstract][Full Text] [Related]
9. Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy.
Chen HW; Liao CH; Ying C; Chang CJ; Lin CM
Clin Immunol; 2006 Apr; 119(1):21-31. PubMed ID: 16406844
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-21 induces T-cell activation and proinflammatory cytokine secretion in rheumatoid arthritis.
Li J; Shen W; Kong K; Liu Z
Scand J Immunol; 2006 Nov; 64(5):515-22. PubMed ID: 17032244
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-21 and the IL-21 receptor: novel effectors of NK and T cell responses.
Parrish-Novak J; Foster DC; Holly RD; Clegg CH
J Leukoc Biol; 2002 Nov; 72(5):856-63. PubMed ID: 12429707
[TBL] [Abstract][Full Text] [Related]
12. IFN-alpha regulates IL-21 and IL-21R expression in human NK and T cells.
Strengell M; Julkunen I; Matikainen S
J Leukoc Biol; 2004 Aug; 76(2):416-22. PubMed ID: 15178704
[TBL] [Abstract][Full Text] [Related]
13. [Antitumoral action of interferons and interleukins in combination with radiotherapy. Part I: immunologic basis].
Herskind C; Fleckenstein K; Lohr J; Li CY; Wenz F; Lohr F
Strahlenther Onkol; 2004 Apr; 180(4):187-93. PubMed ID: 15057428
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-21: an interleukin-2 dependent player in rejection processes.
Baan CC; Balk AH; Dijke IE; Korevaar SS; Peeters AM; de Kuiper RP; Klepper M; Zondervan PE; Maat LA; Weimar W
Transplantation; 2007 Jun; 83(11):1485-92. PubMed ID: 17565322
[TBL] [Abstract][Full Text] [Related]
15. Biology of IL-21 and the IL-21 receptor.
Mehta DS; Wurster AL; Grusby MJ
Immunol Rev; 2004 Dec; 202():84-95. PubMed ID: 15546387
[TBL] [Abstract][Full Text] [Related]
16. IL-21 and IL-21R are not required for development of Th17 cells and autoimmunity in vivo.
Sonderegger I; Kisielow J; Meier R; King C; Kopf M
Eur J Immunol; 2008 Jul; 38(7):1833-8. PubMed ID: 18546146
[TBL] [Abstract][Full Text] [Related]
17. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
[TBL] [Abstract][Full Text] [Related]
18. Common gamma chain cytokines: dissidence in the details.
Alves NL; Arosa FA; van Lier RA
Immunol Lett; 2007 Feb; 108(2):113-20. PubMed ID: 17194484
[TBL] [Abstract][Full Text] [Related]
19. IL-21 in the pathogenesis and treatment of skin diseases.
Costanzo A; Chimenti MS; Botti E; Caruso R; Sarra M; Monteleone G
J Dermatol Sci; 2010 Nov; 60(2):61-6. PubMed ID: 20888735
[TBL] [Abstract][Full Text] [Related]
20. IL-23 promotes tumour incidence and growth.
Langowski JL; Zhang X; Wu L; Mattson JD; Chen T; Smith K; Basham B; McClanahan T; Kastelein RA; Oft M
Nature; 2006 Jul; 442(7101):461-5. PubMed ID: 16688182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]